BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 29, 2017
View Archived Issues
Allergan and Paratek announce results from phase III trials of sarecycline in acne
Read More
EMA committee recommends approval of dinutuximab beta for the treatment of high-risk neuroblastoma
Read More
EC-70124 inhibits NF-kappa-B and STAT3 and reduces tumor growth in prostate cancer xenografts
Read More
Final Pazotest-01 data show transient activity of pazopanib in chemoresistant germ cell tumors
Read More
EpiAxis Therapeutics describes pipeline activity at BIO-Europe Spring
Read More
Cellceutix presents phase II interim analysis for brilacidin in severe oral mucositis
Read More
Perrigo completes divestiture of Tysabri royalty stream rights
Read More
Millendo Therapeutics initiates phase II trial of ATR-101 in endogenous Cushing's syndrome
Read More
3M-052 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine
Read More
FDA grants priority review to Lynparza NDA
Read More
Immune-Onc Therapeutics signs license agreement for cancer immunotherapy
Read More
Shionogi submits NDA in Japan for pediatric use of S-524101
Read More
FDA approves Ocrevus for relapsing and primary progressive forms of MS
Read More
Tadalafil shows efficacy in the treatment of Peyronie's disease
Read More
FDA approves Dupixent for moderate to severe atopic dermatitis
Read More
Mitsubishi Tanabe Pharma and Daiichi Sankyo expand diabetes alliance to cover MT-2412
Read More
Janssen Pharmaceutica NV patents compounds for treating pain
Read More
Jubilant Biosys discovers bromodomain-containing protein 4 inhibitors
Read More
Cephalon identifies new chlorokynurenines
Read More
Tonix initiates phase III HONOR trial of TNX-102 SL for post-traumatic stress disorder
Read More
Basilea Pharmaceutica AG discovers bacterial efflux pump inhibitors
Read More
Calithera achieves milestone with CB-1158 under Incyte collaboration
Read More
Boehringer Ingelheim Pharma GmbH & Co. KG patents tyrosine-protein kinase SYK inhibitors
Read More
Cara Therapeutics reports topline data from Part A of phase II/III trial of CR-845
Read More
Cempra withdraws solithromycin MAA in Europe with plans to resubmit
Read More
Ritter reports phase IIb/III topline data on RP-G28 for lactose intolerance
Read More
Replicel's phase I/II tendon repair study of RCT-01 meets primary endpoint
Read More
Bristol-Myers Squibb, Parker Institute and Cancer Research Institute collaborate in immuno-oncology
Read More
Numares and Oxford University collaborate to develop in vitro diagnostic test for use in MS
Read More